about
Novel structural determinants of single channel conductance and ion selectivity in 5-hydroxytryptamine type 3 and nicotinic acetylcholine receptorsAllopurinol: insights from studies of dose-response relationships.Identification of a 3rd Na+ Binding Site of the Glycine Transporter, GlyT2.Differentiating enantioselective actions of GABOB: a possible role for threonine 244 in the binding site of GABA(C) ρ(1) receptors.Oleoyl-L-carnitine inhibits glycine transport by GlyT2Mutagenic analysis of the intracellular portals of the human 5-HT3A receptor.Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics.Glycine transport inhibitors for the treatment of pain.A hydrophobic area of the GABA ρ₁ receptor containing phenylalanine 124 influences both receptor activation and deactivation.Structural determinants of Ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor.External divalent cations increase anion-cation permeability ratio in glycine receptor channels.Characterization of the effects of charged residues in the intracellular loop on ion permeation in alpha1 glycine receptor channels.Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors.Correction: Identification of a 3rd Na+ Binding Site of the Glycine Transporter, GlyT2.Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptors.Relative impact of residues at the intracellular and extracellular ends of the human GABAC rho1 receptor M2 domain on picrotoxinin activity.Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.Could metformin be used in patients with advanced chronic kidney disease?Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2.Glycine transporter2 inhibitors: Getting the balance right.Barriers and facilitators of appropriate vancomycin use: prescribing context is keyNovel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptorsDynamic modification of a mutant cytoplasmic cysteine residue modulates the conductance of the human 5-HT3A receptorPatients' use of mobile health applications: what general practitioners thinkClinical Pharmacokinetics in Kidney Disease: Fundamental PrinciplesUsability of Reports Generated by a Computerised Dose Prediction SoftwareClinical Pharmacokinetics in Kidney Disease: Application to Rational Design of Dosing RegimensA pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjects
P50
Q24642653-462D4BA5-2379-4829-A595-B1EFC92590D5Q30240163-1FBEFDAC-A794-423C-8AB2-B21FEE72E89DQ36060232-C317E443-911F-4FCE-9800-384E8F8198EFQ36248554-8FA2C3D0-D04E-4DA8-A444-46B866E17044Q36781047-AA05CCFE-94DA-4BEE-9D99-F95C83839ECDQ37272102-52AA78E6-7FE3-4230-82E7-38337E7FD0B8Q38137633-34D01DBA-6787-497A-B324-D14AA1D05A15Q38222971-195126CE-5B8E-4587-B99E-71A1D5E25153Q39194696-4CC8BAA1-B906-4000-A241-13D3934EFD57Q39680758-5CFEE519-A234-4F42-8454-954E294F2B72Q39732910-3B19B26A-3A0E-4D11-8862-5C85791BAACDQ39909903-14E7623F-CA5F-4EF4-885B-62F5B8B07A4AQ40331176-8231ACE2-5A7B-4BBA-90FC-5725414A685EQ42413229-0071BC83-278E-498F-B33A-1312AC90F06FQ46515864-1CAC0848-39AC-47DF-9B5F-87093544ED3BQ46887151-10C64208-CC59-47A2-A878-DF84B77E3CC2Q47819910-82DF0479-DD8D-49B7-B1DB-6FED9F15F1C9Q48304274-027BCDDB-6F25-4186-AB42-CB45DDFC4D49Q48334358-E3011B24-B1F8-41F1-A9ED-059F40F46395Q49061572-27A8795C-19C1-4B70-819D-06DA11542034Q60808905-115EC831-9243-4F32-8AA0-66726E19B55DQ79276333-CFFEEC1A-E6F3-4469-87DE-2D112A70670DQ79475848-27AE9406-4A51-4365-823C-266006659B1BQ89008484-A4AA5193-8857-483E-AFCB-8B4C1B3039A9Q89207253-074F3E27-B09A-4268-A7FC-61416A80E301Q90441762-F55B503D-3D13-44E9-9BFE-D7D946E8EC85Q90451490-52B45926-BA45-4B37-91EF-C178431F8BE3Q94583920-D7049BE6-D5D4-4A7B-8A3A-2210D6C8D084
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jane E Carland
@ast
Jane E Carland
@en
Jane E Carland
@es
Jane E Carland
@nl
type
label
Jane E Carland
@ast
Jane E Carland
@en
Jane E Carland
@es
Jane E Carland
@nl
prefLabel
Jane E Carland
@ast
Jane E Carland
@en
Jane E Carland
@es
Jane E Carland
@nl
P106
P1153
6603168237
P31
P496
0000-0002-1456-876X